Insider Transactions in Q2 2022 at Akebia Therapeutics, Inc. (AKBA)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 08
2022
|
David A Spellman SVP, CFO and Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
200,000
+37.84%
|
-
|
|
Jun 08
2022
|
Adrian Adams |
BUY
Grant, award, or other acquisition
|
Direct |
13,700
+11.56%
|
-
|
|
Jun 08
2022
|
Ron Frieson |
BUY
Grant, award, or other acquisition
|
Direct |
13,700
+50.0%
|
-
|
|
Jun 08
2022
|
Steven C Gilman |
BUY
Grant, award, or other acquisition
|
Direct |
13,700
+19.34%
|
-
|
|
Jun 08
2022
|
Michael W Rogers |
BUY
Grant, award, or other acquisition
|
Direct |
13,700
+17.18%
|
-
|
|
Jun 08
2022
|
Cynthia Smith |
BUY
Grant, award, or other acquisition
|
Direct |
13,700
+17.36%
|
-
|
|
Jun 08
2022
|
Myles Wolf |
BUY
Grant, award, or other acquisition
|
Direct |
13,700
+26.66%
|
-
|
|
Jun 08
2022
|
Leanne M Zumwalt |
BUY
Grant, award, or other acquisition
|
Direct |
13,700
+50.0%
|
-
|
|
Jun 03
2022
|
Steven C Gilman |
SELL
Open market or private sale
|
Direct |
4,567
-9.52%
|
$0
$0.36 P/Share
|
|
May 12
2022
|
Violetta Cotreau SVP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+40.55%
|
-
|
|
May 12
2022
|
Steven Keith Burke SVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
200,000
+32.38%
|
-
|